Remdesivir Gets Clinical Approval: How Does It Cure COVID-19 And Is It Used In India?
Times of India,
The US FDA has allowed the emergency use of experimental antiviral drug ‘Remdesivir’ to treat COVID-19 patients after early…
The US FDA has allowed the emergency use of experimental antiviral drug ‘Remdesivir’ to treat COVID-19 patients after early…
Es weckt große Hoffnungen im Kampf gegen Covid-19: das Mittel Remdesivir. Wie gut es wirkt und was für Nebenwirkungen es hat…
Welcome to Coronavirus Government Global Briefing, Mandarin Premium’s morning update on everything in local and global…
Corona moet uitwoeden, heet het al snel: een virusziekte kun je niet genezen. Of wel? Achter de schermen is de zoektocht in…
A lab technician visually inspects a vial of remdesivir at a facility in California, March 11, 2020.
Direct • La pandémie a dépassé les 250 000 morts dans le monde, dont plus de la moitié en Europe.
4月29日のLancet誌(オンライン)に「 Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre…
Per tidspunkt har over 10 000 personer underskrevet initiativet «1 Day Sooner», som samler inn frivillige til en såkalt Human…
Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, announced last week that a clinical…
Remdesivir may speed time to clinical improvement for patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2…
On Friday, while Rick Bright was in the process of filing what promises to be a damning whistleblower complaint to the…
Researchers changed the primary endpoint during the clinical trial testing remdesivir against COVID-19, a shift that provoked…
„Stell dir vor, es ist Pandemie, und keiner geht hin.“ – Mancher wird sich das in diesen Zeiten denken.
Gilead Sciences chairman and CEO Daniel O’Day Gilead Sciences has committed to producing “millions more” treatment courses of…
Got a TV Licence? You need one to watch live TV on any channel or device, and BBC programmes on iPlayer.
Introduction Gilead's ( GILD ) drug candidate to treat COVID-19, which I call COVID for simplicity, is called remdesivir.
Despejamos algunas dudas sobre este prometedor fármaco cuyos resultados reales aún están en pruebas.
Beskedet kommer sedan Läkemedelsverkets amerikanska motsvarighet, FDA, tillfälligt godkänt Remdesivir för behandling av svårt…
Fredag ble det kjent at USA har hastegodkjent Remdesivir til særskilt behandling av de mest alvorlig syke Covid-19-pasientene.
CBS NEWS Recommended The Food and Drug Administration has authorized the antiviral drug remdesivir for emergency use in…
Markets got very excited (briefly) this week about a study finding a Gilead Sciences drug helped coronavirus patients heal a…
Earlier this week, public health officials revealed that research has shown a benefit in using the experimental drug remdesivir…
El remdesivir és un medicament experimental antiviral, propietat de Gilead Sciences, que mai no ha estat comercialitzat.
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
The US Food and Drug Administration on Friday granted an emergency use authorization to remdesivir, an experimental antiviral…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more money on lobbying Congress and…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
Source: United Kingdom – Executive Government
May 2, 2020 The US Food and Drug Administration has provided Emergency Use Authorisation for the drug remdesivir to be used on…
BBC News | Русская служба 10 мин назад Американские власти официально одобрили использование антивирусного препарата ремдесивир д…
Правообладатель иллюстрации Reuters Американские власти официально одобрили использование антивирусного препарата ремдесивир для…
Hak atas foto Getty Images Badan Pengawas Obat dan Makanan Amerika Serikat (FDA) telah mengizinkan penggunaan secara darurat…
Got a TV Licence? You need one to watch live TV on any channel or device, and BBC programmes on iPlayer.
兩項臨床試驗初步顯示,瑞德西韋 (Remdesivir) 加速康復過程,但無法改善死亡率 1-4 美國和中國科學家於 04/29 ,分別發佈兩項大型臨床試驗,探討以瑞德西韋和安慰劑治療新型冠狀病毒之疾病 (COVID-19) 的初步結果。5/1時,美國食品和…
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Limited evidence suggests remdesivir helps people recover from COVID-19 faster.
La agencia estadounidense reguladora de medicamentos y alimentos (FDA) dio luz verde al antiviral remdesivir -del laboratorio…
Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the…
صحتك منذ 23 ساعة ومازال كورونا الجديد ينتشر حول العالم، ويلهث العلماء لتجربة أي دواء قد يثبت فعاليته ومأمونيته، فما حقيقة فعالية…
The Food and Drug Administration has authorized the antiviral drug remdesivir for emergency use in treating coronavirus cases…
A FDA (Food and Drug Administration), agência do Departamento de Saúde norte-americano responsável pela liberação de alimentos…
Compiled by veteran medical journalist Brian Owens, this roundup of some of the newest science on the COVID-19 pandemic…
The US Food and Drug Administration on Friday granted an emergency use authorization to remdesivir, an experimental antiviral…
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for…
Lately, interest for Gilead ( GILD ) stock has risen dramatically as a consequence of a potential launch of its COVID-19 drug…
May 1 (UPI) -- The U.S. Food and Drug Administration on Friday granted emergency use authorization for the antiviral remdesivir…
Editor’s note: The Salt Lake Tribune is providing free access to critical stories about the coronavirus.
Pandemic exposes U.S. vulnerabilities The Food and Drug Administration has authorized the antiviral drug remdesivir for…
This week, results from a study of the antiviral drug remdesivir showed that the drug reduced recovery time in Covid-19 patients.
Het ebolamedicijn remdesivir zal vanaf maandag in Amerikaanse ziekenhuizen verdeeld worden.
A Food and Drug Administration acabou de autorizar o uso de emergência de remdesivir, um medicamento antiviral experimental…